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Abstract
Many disease states are associated with regional or systemic hypoxia. The study of healthy individuals exposed to high-
altitude hypoxia offers a way to explore hypoxic adaptation without the confounding effects of disease and therapeutic
interventions. Using 31P magnetic resonance spectroscopy and imaging, we investigated skeletal muscle energetics and
morphology after exposure to hypobaric hypoxia in seven altitude-naı¨ve subjects (trekkers) and seven experienced climbers.
The trekkers ascended to 5300 m while the climbers ascended above 7950 m. Before the study, climbers had better
mitochondrial function (evidenced by shorter phosphocreatine recovery halftime) than trekkers: 1661 vs. 2262 s (mean 6
SE, p,0.01). Climbers had higher resting [Pi] than trekkers before the expedition and resting [Pi] was raised across both
groups on their return (PRE: 2.660.2 vs. POST: 3.060.2 mM, p,0.05). There was significant muscle atrophy post-CXE (PRE:
4.760.2 vs. POST: 4.560.2 cm2, p,0.05), yet exercising metabolites were unchanged. These results suggest that, in response
to high altitude hypoxia, skeletal muscle function is maintained in humans, despite significant atrophy.
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Introduction
The metabolic response to impaired regional (e.g. vascular
disease) or systemic (e.g. cardiopulmonary disease) oxygen delivery
is hard to determine, given the confounding effects of the disease
state itself and of therapeutic interventions. The study of healthy
individuals exposed to altitude-related (hypobaric) hypoxia offers
an approach to this problem. As yet, the pattern of response
remains unclear: mitochondrial density, far from increasing [1,2],
may in fact fall [3] (albeit in the context of muscle atrophy [4]),
while enzymes used in anaerobic glycolysis may be upregulated in
the muscle of high altitude natives and acclimatised lowlanders
[5,6] (a suggestion supported by in vitro studies [7]). Hypoxic
cachexia, although well described, remains poorly understood.
There are several hypoxia-tolerance strategies known in other
mammals. For example, sea turtles reduce cellular oxygen consump-
tion during hypoxia by prioritizing certain ATP-consuming processes
at the expense of others [8]. Whether this might also be a feature of
human physiology is not known. In addition, the oxygen-cost of ATP
rephosphorylation might be reduced, although the notion that
oxygen efficiency might be modulated in humans in response to
hypoxia remains deeply controversial [9,10].
Phosphorus magnetic resonance spectroscopy (31P-MRS) and
magnetic resonance imaging (MRI) allow the non-invasive
assessment of mitochondrial function, muscle cross-sectional area
and phosphate metabolism in humans. We thus applied these
techniques to the prospective study of two groups of healthy
individuals exposed to sustained hypobaric hypoxia.
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Methods
Ethics statement
The protocol was approved by the University College
(University of London) Ethical Committee. Written informed
consent was obtained from all participants.
Subjects and experimental outline
We studied fourteen healthy men aged 24–48 years from the
Caudwell Xtreme Everest expedition (CXE) [11]. Of these, seven
were altitude-naı¨ve (‘trekkers’) and seven were experienced
climbers who had previously climbed above 6800 m without
incident (‘climbers’). Subjects underwent health screening to
ensure that they were fit both to complete an ascent to high
altitude and to take part in the planned programme of research
activity. Prior to departure, all subjects attended the Oxford
Centre for Clinical Magnetic Resonance Research (OCMR). On
the morning after an overnight fast, their heights and weights were
recorded, and body mass index (BMI) calculated.
Each subject performed a series of plantar flexion exercises in
the bore of a Siemens Trio 3T clinical magnetic resonance system,
with a dual-tuned 31P and 1H surface coil placed under the widest
part of the right gastrocnemius. The exercise protocol was: 5
minutes rest, 5 minutes very light exercise (warm-up), 7 minutes
recovery, 5 minutes at 4 W (EX1), 7 minutes recovery (REC1), 5
minutes at 5 W (EX2), 5 minutes recovery (REC2). The exercise
work rates were established in pilot experiments, and were
optimized to substantially deplete muscle phosphocreatine while
remaining sustainable throughout the exercise periods. Muscle
cross-sectional area, phosphorus metabolites, phosphocreatine
(PCr) recovery halftime and intracellular pH were calculated as
described below.
All the subjects ascended from Oxford to Everest Base Camp
over approximately 14 days. The trekkers then descended to sea-
level via Kathmandu (1300 m) over 7 days and were retested
within 48 hours. All of the climbers ascended to at least the South
Col (7950 m), and four successfully summitted (8848 m). The
climbers then descended to sea-level over 10–17 days and were
retested approximately a week after leaving Kathmandu. Twelve
subjects (7 trekkers and 5 climbers) returned to OCMR following
CXE.
Nuclear Magnetic Resonance Protocols
A series of gradient-echo ‘scout’ images were acquired in the
transverse, sagittal and coronal planes to ensure correct position-
ing of the leg, and to allow for localized shimming of the region of
interest (ROI). Image parameters were as follows: FOV
2506250 mm, matrix size 2566128, 3 slices per orientation, slice
thickness 8 mm, TR/TE 15/5 ms, excitation flip angle 40u and
bandwidth 180 Hz/Px. This was immediately followed by
localized shimming of the ROI using the phasemap algorithm as
implemented on the 3T system. This increased the local magnet
homogeneity and reduced the linewidths in the acquired spectra.
Prior to the acquisition of the 31P spectra during the leg exercise
protocol, three baseline scans were acquired to allow calculation of
correction factors for partial saturation, caused by both the short
repetition time (TR) used in the spectral acquisition, and nuclear
Overhauser enhancement (NOE). The first baseline scan was
acquired with a long TR to ensure complete relaxation of all
resonances. The scan parameters were as follows: TR 30 s, TE
0.35 ms, bandwidth 2000 Hz, 8 averages, 512 acquired data
points, excitation flip angle 90u and no NOE pulses. The second
baseline scan was run with TR 500 ms, TE 0.35 ms, bandwidth
2000 Hz, 60 averages, 512 acquired data points, excitation flip
angle 25u and 10 rectangular NOE pulses with pulse duration of
10 ms, inter-pulse delay of 10 ms and excitation flip angle of 180u.
The third baseline scan was run with identical parameters to the
second with the exception of no excitation flip angle on the NOE
pulses. The ratio of the resonance areas in the first and third scans
were used to calculate correction factors for partial saturation, and
in the same way the second and third baseline scans were used to
calculate a NOE correction factor.
In the main experiment, a series of 512 individual 31P spectra
were acquired throughout the exercise protocol described above
with a temporal resolution of 5 s. The acquisition parameters
were: TR 500 ms, TE 0.35 ms, bandwidth 2000 Hz, 10 averages,
512 acquired data points, excitation flip angle 25u and 10
rectangular NOE pulses with pulse duration of 10 ms, inter-pulse
delay of 10 ms and excitation flip angle of 180u.
Data processing
Spectra were processed using jMRUI version 2.2 [12] and
quantified using a non-linear least squares algorithm (AMARES
[13]). Resting ATP and total creatine concentrations were
assumed to be 8.2 mM L21 and 42 mM L21 respectively: these
commonly-used concentrations are based on extensive published
values, and are reliable in healthy humans [14]. For muscle
metabolite concentrations during exercise, reported values are the
mean metabolite concentrations during the last minute of exercise
bouts 2 and 3 (i.e. not including data from the ‘warm-up’ bout).
Calculations
The myocellular free adenosine diphosphate (ADP) concentra-
tion was calculated making the standard assumption that that the
creatine kinase reaction was at equilibrium, and using an
equilibrium constant allowing for changes in pH [15].
The free energy available from ATP hydrolysis (DG’ATP, in kJ
M21) was calculated using:
DG0ATP ~ DG0zRT ln
ADP½ | Pi½ 
ATP½ 
 
where DG0 is the standard free energy of ATP hydrolysis
(232.8 kJ M21 [16]), R is the gas constant (8.31 J M21 K21)
and T is temperature (310 K).
In the absence of large changes in pH, the halftime of PCr
recovery after moderate exercise (PCrt1/2) was taken as an inverse
index of mitochondrial function. PCrt1/2 was determined by fitting
a monexponential equation, expressing PCr concentration as a
function of time (t), of the form PCr (t) = 1 – exp (-k t), to data that
had been normalized to resting values. Microsoft Solver was then
used to establish the value of the rate-constant (k) that resulted in
the smallest sum of the squared differences between actual and
predicted PCr values, from which PCrt1/2 = ln (2)/k [17]. The
values reported are the means of the recovery halftimes after both
exercise bouts.
The chemical shift of the phosphate (Pi) peak relative to
phosphocreatine (PCr) (s, in parts per million) was used to
determine intracellular pH, according to the equation:
pH ~ 6:75zlog
s{3:27
5:63{s
 
Muscle cross-sectional area was measured from 1H scout images
(acquired as detailed above) using a freely available stereology
software package (www.easymeasure.co.uk). The measured area
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comprised both the soleus and gastrocnemius muscles, as these are
the active muscles during plantar flexion exercise [18].
Statistical analysis
Statistical testing was carried out using SPSS 16.0 for Mac
(SPSS Inc., Chicago, Illinois, USA). Shapiro-Wilk and Kolmo-
gorov-Smirnov tests were used to establish whether data were
normally distributed; no variable failed these tests of normality.
Unpaired t-tests were used to test for differences between trekkers
and climbers before the expedition. To quantify the significance of
the effects of altitude exposure while controlling for potential
differences between trekkers and climbers, a mixed analysis-of-
variance was used; whether the subject was a trekker or a climber
was coded as a between-subjects factor. There were, however, no
significant between-subjects effects, thus the pre and post data are
reported combined for brevity. Alpha was set at 0.05. All data are
reported as mean 6 S. E. M.
Results
Contrasts between trekkers and climbers at baseline
There was a significant difference in age between trekkers and
climbers, with the climbers being 5 years older. In other respects
the two groups were similar (Table 1).
At rest, the climbers had significantly higher concentrations of
muscle cytosolic inorganic phosphate than the trekkers (climbers:
2.960.2 s vs. trekkers: 2.360.2, n = 14, p,0.05) (Table 2). Other
resting phosphorus metabolites and resting muscle pH were
similar between the groups. During and after recovery from
exercise, there were no differences in phosphorus metabolites or
pH (Table 2). However, there was an unexpected difference in
PCr recovery halftimes (PCrt1/2) between trekkers and climbers
before the expedition, with the trekkers having longer halftimes
(trekkers: 2262 s vs. climbers: 1661 s, n = 14, p,0.01) (Figure 1).
The effect of altitude exposure on trekkers and climbers
The combined subjects had a decreased calf muscle cross-
sectional area following the expedition, from 4.7 to 4.5 cm2 (a loss
of 4%, p,0.05) (Figure 2).
Resting muscle PCr concentration was not changed by exposure
to high altitude. However, Table 3 shows that there were a
number of significant effects of exposure on resting muscle
phosphorus metabolites in the combined subjects. There was a
15% increase in inorganic phosphate (from 2.6 to 3.0 mM).
Despite this, there was a 30% reduction in estimated resting ADP
concentration, and an increase in the free energy available from
ATP hydrolysis (Figure 3).
The concentrations of skeletal muscle high-energy phosphate
metabolites during steady-state plantar-flexion exercise were
unchanged in the combined group following exposure to altitude
(Table 3); however, the mean concentration of PCr after full
recovery from exercise was 11% lower following hypoxic
exposure. This was due to both an absence of post-exercise
phosphocreatine ‘overshoot’ and an exercise-induced loss of PCr
(compared with resting values) after exposure (Figure 4).
There was no effect of altitude exposure on PCr recovery
halftimes (PRE: 2061 s vs. POST: 1962 s, n = 12, p.0.05).
Resting muscle pH was significantly lower post-CXE (Table 3),
and although end-exercise pH was not different post-CXE, muscle
pH was still lower in the acclimatised state after recovery from
exercise. In addition, there was a significant difference in post-
exercise/recovery muscle pH compared with resting (pre-exercise)
muscle pH post-exposure, which was not present in the pre-
acclimatised state (Table 3).
Discussion
The first significant finding of this study was an unexpected
difference in PCr recovery halftime (and hence mitochondrial
function) between climbers and trekkers at baseline, with the climbers
having significantly shorter halftimes (and hence better mitochondrial
function) than their altitude-naı¨ve counterparts. The climbers also
had significantly higher inorganic phosphate concentrations than
trekkers (the possible significance of this difference will be discussed
below). These results were particularly surprising considering the fact
that none of the climbers had been to high altitude for at least 5
months. There was a significant difference in age between the groups,
but this would be expected to result in the opposite effect, at least on
mitochondrial function (the climbers were older, and mitochondrial
function generally declines with age [19]). Nor did the climbers
engage in any structured physical training prior to the expedition,
being aware that differences between individuals in baseline
cardiorespiratory fitness are unrelated to hypoxia tolerance (see
[20] and references therein).
Table 1. Subjects’ descriptive data.
Trekkers (n = 7) Climbers (n = 7) All (n = 14)
Age (years) 31±2 38±3* 3562
Weight (kg) 7462 8366 7863
Height (m) 1.8060.02 1.8060.01 1.8060.01
BMI (kg m22) 2361 2662 2461
Calf muscle CSA (cm2) 4.560.3 4.860.2 4.660.2
All numbers are means 6 S.E.M.
*different from trekkers at p,0.05.
doi:10.1371/journal.pone.0010681.t001
Table 2. High-energy phosphates and pH in human skeletal
muscle: trekkers vs. climbers before hypoxic exposure.
Trekkers (n = 7) Climbers (n = 7)
PCr (mM) Resting 30.760.8 31.360.7
Exercising 18.062.6 18.861.6
After recovery 32.960.5 29.460.8
PCrt1/2 (s) During recovery 22.2±1.6 16.1±1.1 **
Pi (mM) Resting 2.3±0.2 2.9±0.2 *
Exercising 11.661.8 12.962.2
After recovery 1.360.2 1.560.1
ADP (mM) Resting 2863 2662
Exercising 5365 5468
After recovery 2062 2462
DG’ATP (mM J
21) Resting 263.360.5 262.760.3
Exercising 258.060.7 257.460.6
After recovery 265.760.4 264.860.3
pH Resting 7.0960.005 7.1060.003
Exercising 6.9460.05 7.0560.02
After recovery 7.0860.02 7.0860.01
All values are means 6 S.E.M.
*different from trekkers at p,0.05;
**different from trekkers at p,0.01.
doi:10.1371/journal.pone.0010681.t002
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Several possible explanations suggest themselves. First, the
climbers might have been different to the trekkers because years of
climbing had selected against particular phenotypes (for example,
those genetically ill-suited to high altitude hypoxia are unlikely to
continually expose themselves to it). Second, altitude exposure
might induce stable changes in phenotype, perhaps through
epigenetic modifications. Finally, it may be that repeated hypoxic
exposure causes more conventional physiological adaptations that
are unusually persistent. There are no published data on the
timecourse of ‘de-acclimatisation’ after hypoxic exposure. The
most relevant information therefore probably comes from
experiments examining the timecourse of detraining after stopping
prolonged exercise training. Coyle et al. observed that subjects
who had previously been well-trained but who had stopped
training altogether for 84 days still had, on average, a 17% higher
_VO2max than controls who had never trained at all [21]. This was
due to persistent peripheral adaptations (larger mixed-arterial/
venous O2 difference, and therefore better O2 extraction by
skeletal muscle). So despite the fact that none of the climbers had
climbed for at least 5 months prior to this study, it seems possible
that the difference in mitochondrial function observed was a long-
term (or even stable and transmissible) effect of exposure to high-
altitude hypoxia. More work investigating these differences is
clearly warranted, as are comparisons with high-altitude natives
and the offspring of successful climbers.
Exposure to hypobaric hypoxia is associated with an involuntary
loss of body mass [22], whether under laboratory conditions
[23,24,25] or in the field [26,27]. In women, nitrogen balance is
negative soon after exposure to 4300 m altitude [28] and remained
negative in men throughout a 7,102 m ascent [29]. In keeping with
these observations, we observed a significant reduction in muscle
cross-sectional area after hypoxic exposure (Figure 2). There was no
difference in the degree of atrophy between the groups (no statistically
significant effect of trekker/climber grouping).
Such weight loss does not seem to relate simply to excessive
metabolic demands related to exertion. Indeed, physical activity
levels (PAL, assessed as maximal exertional metabolic rate as a
multiple of basal metabolic rate (BMR)) are normally 2.2–2.5 at
sea level, and twice that in trained athletes. However, near
Everest’s summit, PAL is limited to 2.0–2.7, meaning that
Figure 1. Muscle phosphocreatine kinetics in recovery from moderate exercise: differences between experienced climbers and
altitude-naı¨ve subjects. Data shown are means 6 S.E.M.
doi:10.1371/journal.pone.0010681.g001
Figure 2. Individual changes in muscle cross-sectional area
after a trip to high-altitude. Dashed lines are climbers, solid lines are
altitude-naı¨ve subjects. Change in mean values is significant at p,0.05,
n= 12.
doi:10.1371/journal.pone.0010681.g002
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exertional energy loss is minimized [30]. Thus, although perceived
exertion is great, actual energy expenditure is much less [31,32].
The notion that weight loss is not purely due to excessive
metabolic demands is given further credence by the observation
that obese subjects exercising three times each week in 15%
oxygen lose more weight than those exercising in air [33].
A variety of factors are thought to contribute to altitude-induced
weight loss. First, energy expenditure may rise at altitude, due in
part to an increase in BMR [34,35,36,37]. This effect may be
altitude-dependent: BMR has risen by 6% in men at 3,650 m [38],
by 10% at 3,800 m [37], and by 27–28% in men and women by
day 2–3 at 4,300 m [32,36]. In the absence of calorie
supplementation, such absolute increases in BMR do not seem
sustained [36,37,39,40], although BMR per unit mass may
actually remain elevated [38,41].
Second, pro-inflammatory cytokines may play a role. In eight
sea-level residents, the interleukin-6 (IL-6) response to 60 min of
bicycle ergometer exercise was found to be greater during
exposure to acute hypoxia (4100 m altitude) than that seen in
normoxia [42]. After 6 weeks of exposure to 4100 m, IL6 levels
remain elevated [42], a finding in keeping with similar
observations over four days of exposure to 4350 m in males [43]
and with 12 days of exposure to 4300 m in women [44].
Interleukin-6 is implicated in the pathogenesis of cancer-associated
weight loss, driving lipid catabolism and muscle protein catabolism
[45,46], perhaps through both lysosomal (cathepsin) and non-
lysosomal (proteasome) pathways [47].
There was no decline in volume-scaled mitochondrial function
(PCrt1/2) after hypoxic exposure (Table 3). Taken in the context of
significant atrophy, this means that whole muscle aerobic capacity
Figure 3. The effect of altitude exposure on resting high-energy phosphates in skeletal muscle. * different from pre-CXE at p,0.05;
** different from pre-CXE at p,0.01. CXE = Caudwell Xtreme Everest.
doi:10.1371/journal.pone.0010681.g003
Table 3. The effect of altitude exposure on high-energy
phosphates and pH in human skeletal muscle.
PRE POST
PCr (mM) Resting 30.960.6 31.760.7
Exercising 20.261.7 18.861.6
After recovery 32.9±0.5 29.4±0.8**
PCrt1/2 (s) During recovery 2061 1962
Pi (mM) Resting 2.6±0.2 3.0±0.2*
Exercising 11.661.8 12.962.2
After recovery 1.360.2 1.560.1
ADP (mM) Resting 27±2 19±2**
Exercising 5365 5468
After recovery 2062 2462
DG’ATP (mM J
21) Resting 263.0±0.3 263.5±0.2 *
Exercising 258.060.7 257.460.6
After recovery 265.760.4 264.860.3
pH Resting 7.10±0.003 7.06±0.006***
Exercising 6.9960.03 7.0060.02
After recovery 7.08±0.01 7.04±0.01**
Values are means 6 SEM (n=12).
*different from PRE at p,0.05;
**different from PRE at p,0.01;
***different from PRE at p,0.001. There were no significant effects of trekker/
climber grouping.
doi:10.1371/journal.pone.0010681.t003
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was reduced. Yet, rather surprisingly in the face of significant
muscle atrophy and a loss of aerobic capacity, the expedition did
not have any adverse effects on muscle function during exercise.
Subjects were able to complete the same exercise tasks pre and
post exposure, and exercising metabolites were unchanged
(Table 3). Although at variance with previous reports that muscle
mitochondrial enzyme activities (per unit of cross sectional area)
are decreased by hypoxic exposure [4], our results suggest that in
vivo function might somehow be maintained. Further experiments
specifically targeted at illuminating changes in muscle mitochon-
drial function in vivo in response to hypoxic exposure are required.
When fully recovered after a period of exercise, PCr concentrations
are often higher than pre-exercise values, a phenomenon known as
PCr ‘overshoot’ [48]. There is very little published literature
regarding the mechanisms underlying PCr overshoot in skeletal
muscle. One hypothesis states that PCr overshoot is the result of a
slow decay in one of the signals that directly activates oxidative
phosphorylation [49]. If this were the case, then the data here suggest
a tightening of off-exercise oxygen kinetics, perhaps to prevent
unnecessary oxygen consumption. An alternative explanation would
be that inorganic phosphate is being lost during exercise (perhaps due
to calcium-phosphate precipitation [50]).
There were several changes in resting muscle high-energy
phosphates after hypoxic exposure. While the changes in estimated
free [ADP] will be discussed below, the increase in muscle
phosphate is noteworthy because it mirrors a difference that was
observed between the climbers and trekkers at baseline. There are
two possible mechanisms for an increased steady-state cell [Pi].
The first is an increased Na+-dependent Pi uptake. This
mechanism is poorly understood, but can be driven by an increase
in insulin, possibly indirectly via effects on the Na+ gradient [51].
The second theoretical possibility is reduced permeability to Pi
efflux, although convincing examples are currently lacking.
Our calculations of [ADP] rest on a number of assumptions
regarding muscle metabolite (ATP and creatine) concentrations.
Although these assumptions are generally sound [14], one cannot
discount the possibility that the extreme conditions experienced by
our subjects invalidated them. Thus our findings need to be
interpreted with caution. PCr concentration was calculated from
the PCr/ATP ratio (assuming an intramuscular [ATP] of
8.2 mM L21) and was unchanged by the expedition, strongly
suggesting that [ATP] was also unchanged. However, we did not
directly measure creatine and the observed increase in calculated
[ADP] could be accounted for by an increase in total creatine.
Despite these reservations, it seems reasonable that [ADP] might
have decreased in response to hypoxia. It is now widely accepted that
mitochondrial oxidative rate is matched to ATP demand by feedback
mediated by intracellular phosphorylation potential or some function
of it. Therefore a reduction in the resting ADP concentration would
indicate either a change in the control parameters linking oxidative
rate to [ADP] or a reduction in resting muscle oxidative rate.
Resting (but not exercising) pH was significantly lower following
exposure. This was not a result of systemic ketoacidosis, as there
was no correlation between pH and b-hydroxybutyrate (correla-
tion not shown). We therefore suggest that it was the result of
either increased metabolic proton production or decreased
capacity for cellular proton extrusion (for example, a reduced
activity or sensitivity of Na+/H+-ATPase).
Limitations
There are a number of limitations to this study. First, the
trekkers and climbers were different from each other before the
study began and we have chosen to treat the subjects as a single
group (as well as separately). We justify this based on an absence of
any statistical evidence that the groups responded differently.
Second, several of the climbers were very slow descending from
altitude before revisiting Oxford. However, this has provided an
unexpected benefit: because there were no differences between the
responses of trekkers (who returned to Oxford immediately) and
climbers, it is unlikely that the observed changes were acute
responses. For example, this shows that the post-exposure
reduction in muscle pH (equally present in both groups) was not
due to an acute disturbance in acid-base status.
Figure 4. The effect of altitude exposure on phosphocreatine ‘overshoot’ in skeletal muscle. Values are means over the last minute of
each period. CXE = Caudwell Xtreme Everest expedition, EXx = exercise bout x, RECx = recovery period after exercise bout x. ** different from pre-
CXE at p,0.01; 1End-REC1 PCr is different from resting PCr pre-CXE at p,0.05; "End-REC2 PCr is different from resting PCr post-CXE at p,0.05.
doi:10.1371/journal.pone.0010681.g004
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Conclusions
We used magnetic resonance spectroscopy and imaging to study
the effects of a trip to high altitude (Mount Everest) on a mixed
cohort of altitude-naı¨ve trekkers and experienced climbers. The
climbers had unexpectedly better mitochondrial function than the
trekkers at baseline. Both groups responded similarly to the
hypoxic insult. Climbers had higher resting [Pi] than trekkers
before the expedition and resting [Pi] was raised across both
groups on their return. There was significant muscle atrophy post-
CXE, yet exercising metabolites were unchanged. These results
suggest that, in response to high altitude hypoxia, skeletal muscle
function is maintained in humans, despite significant atrophy.
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